Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study
Randall E. Brand(University of Pittsburgh), Thomas C. King, Aimee L. Lucas(Icahn School of Medicine at Mount Sinai), Corinne Decicco(Beth Israel Deaconess Medical Center), Bryson W. Katona(University of Pennsylvania), Marién Castillo(Instituto Cajal), Arto Kokkola(Helsinki University Hospital), Julie Earl(Instituto Cajal), Alfredo Carrato(Hospital General Universitario de Elche), Svein Olav Bratlie(Sahlgrenska University Hospital), Daniel C. Chung(Massachusetts General Hospital), Jan Persson(Sahlgrenska University Hospital), Linda Dexlin Mellby(Immunovia (Sweden)), A. James Moser(Beth Israel Deaconess Medical Center)
Cited by 42
Related Papers
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k